Ads
related to: sanjiv goenka group stocks
Search results
Results From The WOW.Com Content Network
In addition, the RP-Sanjiv Goenka Group has four captive power plants, with a combined capacity of 76 MW, which are fuelled by the process waste gas produced at its four carbon black manufacturing units in India. There is a 40 MW power plant running on coal washery rejects and carbonaceous shale at the coal mining operations in Asansol.
RP-Sanjiv Goenka Group (also known as RPSG Group) is an Indian multinational conglomerate headquartered in Kolkata. The founding was the result of a divesture by RPG Enterprises in 2011. The Group's businesses include power and energy, carbon black manufacturing, retail, IT-enabled services, FMCG, media and entertainment, infrastructure and ...
Sanjiv Goenka (born 29 January 1961) [7] is an Indian Billionaire Businessman. [8] He is the founder and chairman of RPSG Group and an early-stage investor. With a US$6 billion asset base and US$4.3 billion revenue, this multinational conglomerate is headquartered in Kolkata.
Firstsource Solutions Limited is an Indian business process management company headquartered in Mumbai, India.It is owned by RP-Sanjiv Goenka Group. [4]Firstsource provides business process management in the banking and financial services, customer services, telecom and media, and healthcare sectors.
Stock market, mutual funds P A Container Corporation of India: Industrials Railroads New Delhi: 1988 ... RP-Sanjiv Goenka Group: Conglomerate ...
Its stock trades at 27.4 times forward earnings, representing a meaningful premium to the benchmark S&P 500's 24.2 multiple. This premium valuation reflects investors' expectations for continued ...
Saregama India Ltd., [a] formerly known as The Gramophone Company of India Ltd., is India's oldest music record label company, owned by the RP-Sanjiv Goenka Group of companies. [2] [3] The company is listed on the NSE and the BSE with its head office located in Kolkata and other offices in Mumbai, Chennai and Delhi.
This strong market position generates substantial cash flows that support shareholder returns. Turning to the specifics, the pharmaceutical giant offers investors a 4.3% dividend yield backed by a ...